FundedIQ
Health Care

NanoPass Technologies

NanoPass is where cutting-edge technology intersects with healthcare innovation. We pioneer revolutionary solutions in intradermal delivery, reshaping the landscape of therapeutic and medical aesthetic procedures using our proprietary technology towards a precise, safe, and efficient future. Our MicronJet™ intradermal delivery product platform has redefined the standard of care. Join the Intradermal precision revolution! NanoPass's IP-backed product, the MicronJet (registered with the US FDA, the EU, Brazil, China, Australia and other countries), is the most advanced hollow microneedles device available today. Its excellent performance is backed by more than 50 clinical studies. The Company has concluded the world's first intradermal pandemic flu vaccine study and additional seasonal flu studies, demonstrating equivalent or superior immunogenicity to standard delivery using only 20% of the dose. The company is backed by prominent Israeli and US investors Ă˝and medical device companies, including IHCV, Ofer Hi-Tech, D-Partners, WFD Ventures and Elcam Medical. NanoPass recently closed a new round of financing, led by Israel Health Care Ventures (IHCV) NanoPass is continuously engaged in joint clinical development with top pharmaceutical companies, to demonstrate the benefits of its technology for various indications.

www.nanopass.com Ness Ziona, Israel 11-50 employees
Total raised
$4.0M
Rounds
1
Latest
Seed
Jul 2024

NanoPass is where cutting-edge technology intersects with healthcare innovation. We pioneer revolutionary solutions in intradermal delivery, reshaping the landscape of therapeutic and medical aesthetic procedures using our proprietary technology towards a precise, safe, and efficient future. Our MicronJet™ intradermal delivery product platform has redefined the standard of care. Join the Intradermal precision revolution! NanoPass's IP-backed product, the MicronJet (registered with the US FDA, the EU, Brazil, China, Australia and other countries), is the most advanced hollow microneedles device available today. Its excellent performance is backed by more than 50 clinical studies. The Company has concluded the world's first intradermal pandemic flu vaccine study and additional seasonal flu studies, demonstrating equivalent or superior immunogenicity to standard delivery using only 20% of the dose. The company is backed by prominent Israeli and US investors Ă˝and medical device companies, including IHCV, Ofer Hi-Tech, D-Partners, WFD Ventures and Elcam Medical. NanoPass recently closed a new round of financing, led by Israel Health Care Ventures (IHCV) NanoPass is continuously engaged in joint clinical development with top pharmaceutical companies, to demonstrate the benefits of its technology for various indications.

NanoPass Technologies has raised $4.0M across 1 round. Its most recent round was a Seed of $4.0M in Jul 2024. Full funding history, investors, and team are detailed below.

Funding history

1 round · 1 visible Unlock with plan

1 round on record.

Date
Round
Amount
Lead investor
Jul 15, 2024
Seed
$4.0M

Unlock the lead investor and full details for this round.

Unlock funding history →

People

Unlock with plan

Founders, executives, and decision-makers — sourced and refreshed weekly.

Name
Role
LinkedIn

See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.

Unlock people data →

NanoPass Technologies is featured in

Similar companies

Inspira Technologies

Inspira Technologies is a cutting-edge medical technology company that specializes in the acute respiratory care sector. Their unique ART technology aims to meet the demand for treatment that supports patients with acute respiratory conditions without the need for mechanical ventilation while they are conscious and breathing independently.

Series Unknown $1.0M
Alpha Tau Medical

Alpha Tau Medical is an Israeli medical device company that focuses on research, development and commercialization of Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) for the treatment of solid cancer. The Alpha DaRT technology was developed in 2003 at Tel Aviv University. Since then, numerous preclinical trials have found the technology to be effective and safe for various indications and anatomic areas. The findings were published in 12 papers in peer-reviewed scientific journals. Today, the company is running its first clinical trial with very promising preliminary results.

Series Unknown $20.0M
Adenocyte

Adenocyte is a privately held medical technology business that focuses on early diagnosis of adenocarcinoma and its precancerous precursor.

Series Unknown $10.0M
Vortex Imaging

Vortex Imaging develops medical imaging devices.

Series Unknown $12.0M
Urologic Health

Urologic Health developing innovative solutions to improve bladder function diagnosis, monitoring, and treatment of urinary disorders.

Seed $11.0M
VISIONIX

VISIONIX develops, manufactures and distributes innovative equipment and provides a complete solution for ophthalmologists, optometrists, opticians and optical laboratories. VISIONIX developed its products by relying on its innovative patented PowerMap TM technology, which provides simultaneous multipoint measurements of all the parameters of a lens. The technology, originated by the impressive list of VISIONIX scientists, is based on Hartman Wavefront 3-D technology. Visionix is partnered with Briot since 2010.

Series Unknown $220M
Fize Medical

Fize Medical is a health care company based in Israel.

Series A $6.0M
Synchrony Medical

Synchrony Medical is a clinical stage medical device company developing LibAirty, a next generation, home-use, airway clearance system designed to help patients with chronic lung disease such as COPD and CF maintain clear lungs with a short, daily, proficient treatment.

Series Unknown $1.0M
TopGum Industries

TopGum has developed a highly scalable patent-pending delivery system with the capacity to deliver a wide range of nutrients and API, manufactured to the highest health and safety standards.

Series Unknown $45.4M
Nanox Imaging

Nanox offers the Nanox System as a preventative healthcare Medical Screening As A Service (MSaaS). Nanox field-effect cathode technology was originally developed for use in high-definition flat panel displays. Over time, the manufacturing processes were ported from glass to silicon, enabling enormous increases in power density and uniformity. After more than 20 years of research and development, with over $1B invested, their team of engineers has developed unique intellectual property, patents, and capability to design and build high-powered field-effect cathodes that outperform all previous efforts. Nanox’s proprietary cold cathode technology greatly expands the capabilities of X-ray imaging. At the core of their high-powered cold cathode is a “chip” of nano-scale structures created using proprietary nanofabrication techniques. The chip is designed to support various use cases of medical imaging and will be supported by peripheral technologies in order to translate their benefits into various real-world applications.

Series Unknown $15.0M
QuantHealth

QuantHealth is an organization that produces software using artificial intelligence technology for drug development data. This software is utilized for conducting patient-focused medication simulations, with the aim of expediting and reducing the risks associated with drug development. By merging data from various sources within clinical and drug development fields, the company's software can forecast how patients will respond to both existing and innovative treatments. This enables pharmaceutical and biotechnology clients to conduct different versions of their clinical trials, enhancing trial design and boosting the chances of successful trials. As a result, QuantHealth aids in uncovering new clinical prospects and optimization strategies.

Series Unknown
Microbot Medical

Microbot Medical is a company that creates innovative medical devices using micro-robotic technology. They are dedicated to improving surgical outcomes for patients by allowing more physicians to treat more patients. Currently, they are working on the development of two products: the Self Cleaning Shunt for hydrocephalus treatment and the TipCAT endoscope for colonoscopy procedures.

Series Unknown $630k
Free · Every Monday

Know which startups just got funded. Every week.

Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.

Free. Sent every Monday. Unsubscribe anytime.